Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.
Castillo-Mancilla JR, Meditz A, Wilson C, Zheng JH, Palmer BE, Lee EJ, Gardner EM, Seifert S, Kerr B, Bushman LR, MaWhinney S, Anderson PL.
Castillo-Mancilla JR, et al.
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):495-501. doi: 10.1097/QAI.0000000000000529.
J Acquir Immune Defic Syndr. 2015.
PMID: 25763783
Free PMC article.